Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 2/2018

17.07.2017 | Original Article

Thrombolysis for stroke in Ireland: increasing access and maintaining safety in a challenging environment

verfasst von: P. McElwaine, J. McCormack, C. Brennan, H. Coetzee, P. Cotter, R. Doyle, A. Hickey, F. Horgan, C. Loughnane, C. Macey, P. Marsden, D. McCabe, R. Mulcahy, I. Noone, E. Shelley, T. Stapleton, D. Williams, P. Kelly, J. Harbison

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

In the setting of a national audit of acute stroke services, we examined the delivery of thrombolytic therapy for ischaemic stroke and whether current practice was achieving safe outcomes and consistent delivery for patients.

Method

Data obtained from the recent national stroke audit was compared against previous Irish audit, the most recent SSNAP UK stroke audit and the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) study.

Results

Thrombolysis was provided in 27 acute hospitals throughout Ireland during the period assessed with 82% (22/27) providing 24/7 access, the remaining sites using redirect policies. Decision to thrombolyse was made by stroke trained consultants in 63% (17/27) of units, with general physicians and emergency medicine consultants covering the other units. Thrombolysis rate for non-haemorrhagic stroke was 11% (n = 80/742, CI 95% ±2.23) versus a 1% rate in the 2008 audit. Sites receiving patients through a redirect policy had the highest thrombolysis rate, an average of 24%. Nearly 30% of cases were thrombolysed on the weekend. Eighty-three percent of cases were managed in a stroke unit at some time during admission versus 54% of the national total cases. Thirty-seven percent of patients were ≥80 years old. The mortality rate was 11.3% versus the national mortality rate for non-thrombolysed ischaemic strokes of 10% (p > 0.5), and this is comparable to the SITS-MOST 2007 study 3-month mortality rate of 11.3% (p > 0.5).

Conclusion

Stroke thrombolysis is being effectively and safely provided in acute stroke services in Ireland despite regular involvement of non-specialist staff. There is still potential to improve thrombolysis rate.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Disorders TNIoN, Group Sr-PSS (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1588CrossRef Disorders TNIoN, Group Sr-PSS (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581–1588CrossRef
2.
Zurück zum Zitat Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W et al Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369(9558):275–282 Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W et al Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369(9558):275–282
3.
Zurück zum Zitat Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329CrossRefPubMed Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329CrossRefPubMed
4.
Zurück zum Zitat Horgan F, Murphy S, Hickey A, McGee H, O'Neill D (2009) Results from the first Irish National Audit of Stroke Care (INASC)—clinical audit. Cerebrovasc Dis 27:228 Horgan F, Murphy S, Hickey A, McGee H, O'Neill D (2009) Results from the first Irish National Audit of Stroke Care (INASC)—clinical audit. Cerebrovasc Dis 27:228
5.
Zurück zum Zitat Health Do. Changing cardiovascular health: National Cardiovascular Health Policy 2010-2019. Government Publications, 2010–05. Report No.: 0-7557-7639-9 Health Do. Changing cardiovascular health: National Cardiovascular Health Policy 2010-2019. Government Publications, 2010–05. Report No.: 0-7557-7639-9
7.
Zurück zum Zitat McElwaine P, McCormack J, Harbison J. National Stroke Audit 2015. Irish Heart Foundation (IHF) & Health Service Executive, 2016-02. Report No.: 978-1-78602-006-2 McElwaine P, McCormack J, Harbison J. National Stroke Audit 2015. Irish Heart Foundation (IHF) & Health Service Executive, 2016-02. Report No.: 978-1-78602-006-2
8.
Zurück zum Zitat Lees KR, Ford GA, Muir KW, Ahmed N, Dyker AG, Atula S et al (2008) Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM 101(11):863–869CrossRefPubMed Lees KR, Ford GA, Muir KW, Ahmed N, Dyker AG, Atula S et al (2008) Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM 101(11):863–869CrossRefPubMed
9.
Zurück zum Zitat Scherf S, Limburg M, Wimmers R, Middelkoop I, Lingsma H (2016) Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better? BMC Neurol 16(1):1–6CrossRef Scherf S, Limburg M, Wimmers R, Middelkoop I, Lingsma H (2016) Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better? BMC Neurol 16(1):1–6CrossRef
10.
Zurück zum Zitat Hillmann S, Wiedmann S, Fraser A, Baeza J, Rudd A, Norrving B et al (2015) Temporal changes in the quality of acute stroke care in five national audits across Europe. Biomed Res Int 2015:432497CrossRefPubMedPubMedCentral Hillmann S, Wiedmann S, Fraser A, Baeza J, Rudd A, Norrving B et al (2015) Temporal changes in the quality of acute stroke care in five national audits across Europe. Biomed Res Int 2015:432497CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Price CI, Clement F, Gray J, Donaldson C, Ford GA (2009) Systematic review of stroke thrombolysis service configuration. Expert Rev Neurother 9(2):211–233CrossRefPubMed Price CI, Clement F, Gray J, Donaldson C, Ford GA (2009) Systematic review of stroke thrombolysis service configuration. Expert Rev Neurother 9(2):211–233CrossRefPubMed
13.
Zurück zum Zitat Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C et al (2016) Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke 11(1):134–147CrossRefPubMed Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C et al (2016) Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke 11(1):134–147CrossRefPubMed
14.
Zurück zum Zitat Ringelstein EB, Chamorro A, Kaste M, Langhorne P, Leys D, Lyrer P et al (2013) European Stroke Organisation recommendations to establish a stroke unit and stroke center. Stroke 44(3):828–840CrossRefPubMed Ringelstein EB, Chamorro A, Kaste M, Langhorne P, Leys D, Lyrer P et al (2013) European Stroke Organisation recommendations to establish a stroke unit and stroke center. Stroke 44(3):828–840CrossRefPubMed
15.
Zurück zum Zitat Rudd AG, Irwin P, Rutledge Z, Lowe D, Wade D, Morris R et al (1999) The national sentinel audit for stroke: a tool for raising standards of care. J R Coll Physicians Lond 33(5):460–464PubMed Rudd AG, Irwin P, Rutledge Z, Lowe D, Wade D, Morris R et al (1999) The national sentinel audit for stroke: a tool for raising standards of care. J R Coll Physicians Lond 33(5):460–464PubMed
16.
Zurück zum Zitat The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379(9834):2352–63 The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379(9834):2352–63
17.
Zurück zum Zitat Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee T-H, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 0(0):null Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee T-H, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 0(0):null
Metadaten
Titel
Thrombolysis for stroke in Ireland: increasing access and maintaining safety in a challenging environment
verfasst von
P. McElwaine
J. McCormack
C. Brennan
H. Coetzee
P. Cotter
R. Doyle
A. Hickey
F. Horgan
C. Loughnane
C. Macey
P. Marsden
D. McCabe
R. Mulcahy
I. Noone
E. Shelley
T. Stapleton
D. Williams
P. Kelly
J. Harbison
Publikationsdatum
17.07.2017
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 2/2018
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1661-5

Weitere Artikel der Ausgabe 2/2018

Irish Journal of Medical Science (1971 -) 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.